IngentaConnect Severe atopic dermatitis is associated with a reduced frequency o...

Authors: Seneviratne, S. L.¹; Jones, L.¹; Bailey, A. S.¹; Black, A. P.¹; Ogg, G S.

Source: Clinical & Experimental Dermatology, Volume 31, Number 5, September 2006 , pp. 689-694(6)

Abstract:

Summary Background.

Several studies have investigated levels of T-cell-derived interleukin (IL)-10 in individuals with atopic dermatitis, with conflicting results. Aims/Hypothesis.

In order to address whether stratification of disease severity may help resolve the different findings, the hypothesis was tested that individuals with severe atopic dermatitis have a lower frequency of circulating IL-10-producing, allergen-specific CD4+ T cells than do individuals with mild disease. Methods.

Using peripheral blood mononuclear cells derived from individuals with severe (n = 12) and mild atopic dermatitis (n = 10) and from nonatopic controls (n = 10), we investigated production by CD4+ T cells of tumour necrosis factor (TNF)-α, IL-4, IL-5, IL-13 and IL-10 in response to phorbol myristate acetate/ionomycin and Der p1 allergen. Results.

It was observed that there were significantly higher frequencies of allergen-specific circulating CD4+ T cells producing TNF-α- IL-4-, IL-5- and IL-13, and lower frequencies of these cells producing IL-10 in individuals with severe atopic dermatitis compared with mildly affected individuals and nonatopic controls (P < 0.01 for all comparisons). Furthermore, the Der p1-specific CD4+ T cells were enriched within the subset of cells positive for cutaneous lymphocyte-associated antigen. Conclusions.

Analysis of levels of allergen-specific CD4+ T-cell production of IL-10 in relation to disease severity argues in favour of a role for IL-10 in the control of atopic dermatitis.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax Refund Policy

Severe atopic dermatitis is associated with a reduced frequency of IL-10 producing allergen-specific CD4+ T cells